-
1Academic Journal
Authors: V. V. Protoshchak, M. V. Paronnikov, E. G. Karpushchenko, A. V. Sleptsov, P. A. Babkin, N. P. Kushnirenko, R. V. Novikov, В. В. Протощак, М. В. Паронников, Е. Г. Карпущенко, А. В. Слепцов, П. А. Бабкин, Н. П. Кушниренко, Р. В. Новиков
Source: Cancer Urology; Том 20, № 1 (2024); 103-108 ; Онкоурология; Том 20, № 1 (2024); 103-108 ; 1996-1812 ; 1726-9776
Subject Terms: чрескожная резекция, tumor of the renal pelvis, bladder cancer, recurrence, progression, transcutaneous resection, опухоль лоханки, рак мочевого пузыря, рецидив, прогрессия
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1699/1517; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1699/1374; Sung H., Ferlay J., Siegel R.L. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209–49. DOI:10.3322/caac.21660; National Cancer Institute. SEER Stat Fact Sheets: Bladder Cancer, 2015 Available at: http://seer.cancer.gov/statfacts/html/urinb.html [cited March 6, 2015].; Cosentino M., Palou J., Gaya J.M. et al. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol 2013;31(1):141–5. DOI:10.1007/s00345-012-0877-2; Margulis V., Shariat S.F., Matin S.F. et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009;115(6):1224–33. DOI:10.1002/cncr.24135; Roupret M., Siesen T., Birtle A. et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. Eur Urol 2023;84(1):49–64. DOI:10.1016/j.eururo.2023.03.013; Rosenthal D.L., Wojcik E.M., Kurtycz D.F.I. The Paris System for reporting urinary cytology. Springer, 2016.; Мартов А.Г., Ергаков Д.В., Андронов А.С. Уротелиальный рак верхних мочевыводящих путей: возможно ли удаление опухоли единым блоком? Онкоурология 2022;18(3):123–7. DOI:10.17650/1726-9776-2022-18-3-123-127; Motamedinia P., Keheila M., Leavitt D.A. et al. The expanded use of percutaneous resection for upper tract urothelial carcinoma: a 30-year comprehensive experience. J Endourol 2016;30(3):262–7. DOI:10.1089/end.2015.0248; Lucas S.M., Svatek R.S., Olgin G. et al. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int 2008;102(2):172–6. DOI:10.1111/j.1464-410X.2008.07535.x; Belugina R., Kirsanov D., Protoshchak V. et al. Developing non-invasive bladder cancer screening methodology through potentiometric multisensor urine analysis. Talanta 2021;234:122696. DOI:10.1016/j.talanta.2021.122696; Habuchi T., Takahashi R., Yamada H. et al. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 1993;342(8879):1087–8. DOI:10.1016/0140-6736(93)92066-3; Mistretta F.A., Carrion D.M., Nazzani S. et al. Bladder recurrence of primary upper tract urinary carcinoma following nephroureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer. Minerva Urol Nefrol 2019;71(3):191–200. DOI:10.23736/S0393-2249.19.03311-3; Jones T.D., Wang M., Eble J.N. et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 2005;11(18):6512–9. DOI:10.1158/1078-0432.CCR-05-0891; https://oncourology.abvpress.ru/oncur/article/view/1699